chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor, Vaccination complication
Clinical narrative: shaking that She thought of like having seizure; feverish feeling; troubled sleeping; joint pain; achy feeling; tiredness; only had one experience; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INSOMNIA (troubled sleeping), TREMOR (shaking that She thought of like having seizure), VACCINATION COMPLICATION (only had one experience), ARTHRALGIA (joint pain) and MYALGIA (achy feeling) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CARVEDILOL, SPIRONOLACTONE, LOSARTAN, MULTIVITAMINS [VITAMINS NOS] and CALCIUM for an unknown indication.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced VACCINATION COMPLICATION (only had one experience). On 18-Mar-2021, the patient experienced FATIGUE (tiredness). On 20-Mar-2021, the patient experienced INSOMNIA (troubled sleeping), ARTHRALGIA (joint pain) and MYALGIA (achy feeling). On 21-Mar-2021, the patient experienced TREMOR (shaking that She thought of like having seizure) and PYREXIA (feverish feeling). On 20-Mar-2021, FATIGUE (tiredness) had resolved. On 21-Mar-2021, TREMOR (shaking that She thought of like having seizure) had resolved. On 22-Mar-2021, INSOMNIA (troubled sleeping), VACCINATION COMPLICATION (only had one experience), ARTHRALGIA (joint pain), MYALGIA (achy feeling) and PYREXIA (feverish feeling) had resolved.            The patient was advised by primary care doctor to report these events as the side effects that occurred several days after the injection. The patient has not experienced any more side effects since the first experience. The patient consented to healthcare provider followup.  No treatment information was provided by the reporter.     Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Significant follow-up- Event added, first dose information was added, updated start and stop dates of events, and changed the primary regimen of the vaccine.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Erythema, Joint swelling, Pain in extremity, Peripheral swelling
Clinical narrative: Sore first finger and joint; Red first finger and joint; Swollen arm /swollen first finger and joint; Swollen first finger and joint; Sore first finger and joint; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Sore first finger and joint), ERYTHEMA (Red first finger and joint), PERIPHERAL SWELLING (Swollen arm /swollen first finger and joint), JOINT SWELLING (Swollen first finger and joint) and ARTHRALGIA (Sore first finger and joint) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN, LEVOTHYROXINE and ACETYLSALICYLIC ACID (ASPIRINE) for an unknown indication.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced ARTHRALGIA (Sore first finger and joint). On 24-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore first finger and joint), ERYTHEMA (Red first finger and joint), PERIPHERAL SWELLING (Swollen arm /swollen first finger and joint) and JOINT SWELLING (Swollen first finger and joint). The patient was treated with AMOXICILLIN at an unspecified dose and frequency and DICLOFENAC at an unspecified dose and frequency. On 22-Mar-2021, PAIN IN EXTREMITY (Sore first finger and joint), ERYTHEMA (Red first finger and joint), PERIPHERAL SWELLING (Swollen arm /swollen first finger and joint) and ARTHRALGIA (Sore first finger and joint) had resolved. At the time of the report, JOINT SWELLING (Swollen first finger and joint) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other  treatment  medication included sodium cream.   The patient was instructed by the doctor to not to take second dose due to adverse event.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Temperature 101.3; This spontaneous case was reported by a physician and describes the occurrence of PYREXIA (Temperature 101.3) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced PYREXIA (Temperature 101.3). At the time of the report, PYREXIA (Temperature 101.3) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Mar-2021, Body temperature: 101.3 (High) 101.3 increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. The patient did not take any treatment medication.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Swelling face, Swollen tongue
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of swelling face (facial swelling), swollen tongue (tongue swelling) and pyrexia (low-grade fever) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Mar 18, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19  vaccine), intramuscular; 1 dosage form. Mar 20, 2021, patient experienced swelling face (facial swelling), swollen tongue (tongue swelling) and pyrexia (low-grade fever). On Mar 20, 2021, swelling face (facial swelling), swollen tongue (tongue swelling) and pyrexia (low-grade fever) resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication or treatment information reported.
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Somnolence
Clinical narrative: Very sleepy and tired; Very sleepy and tired; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Very sleepy and tired) and FATIGUE (Very sleepy and tired) in a 91-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Heart disorder.   On 20-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced SOMNOLENCE (Very sleepy and tired) and FATIGUE (Very sleepy and tired). At the time of the report, SOMNOLENCE (Very sleepy and tired) and FATIGUE (Very sleepy and tired) had not resolved. Not Provided          No concomitant medication details was reported. No treatment medication details was reported.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Non-significant follow-up received, patient denied further follow-up.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Nausea, Pain, Rash morbilliform, Vaccination complication
Clinical narrative: Had a bad reaction; Something that looked like the measles but instead of being red, they were white looking; Diarrhea; Some aches and pains; Throwing up; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Had a bad reaction), RASH MORBILLIFORM (Something that looked like the measles but instead of being red, they were white looking), DIARRHOEA (Diarrhea), PAIN (Some aches and pains) and VOMITING (Throwing up) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. NWKDOH) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced VACCINATION COMPLICATION (Had a bad reaction), RASH MORBILLIFORM (Something that looked like the measles but instead of being red, they were white looking), DIARRHOEA (Diarrhea), PAIN (Some aches and pains), VOMITING (Throwing up) and NAUSEA (Nausea). At the time of the report, VACCINATION COMPLICATION (Had a bad reaction), RASH MORBILLIFORM (Something that looked like the measles but instead of being red, they were white looking), DIARRHOEA (Diarrhea), PAIN (Some aches and pains), VOMITING (Throwing up) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Had a bad reaction; Something that looked like the measles but instead of being red, they were white looking; Diarrhea; Some aches and pains; Throwing up; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Had a bad reaction), RASH MORBILLIFORM (Something that looked like the measles but instead of being red, they were white looking), DIARRHOEA (Diarrhea), PAIN (Some aches and pains) and VOMITING (Throwing up) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. NWKDOH) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced VACCINATION COMPLICATION (Had a bad reaction), RASH MORBILLIFORM (Something that looked like the measles but instead of being red, they were white looking), DIARRHOEA (Diarrhea), PAIN (Some aches and pains), VOMITING (Throwing up) and NAUSEA (Nausea). At the time of the report, VACCINATION COMPLICATION (Had a bad reaction), RASH MORBILLIFORM (Something that looked like the measles but instead of being red, they were white looking), DIARRHOEA (Diarrhea), PAIN (Some aches and pains), VOMITING (Throwing up) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Pain in extremity, Paranasal sinus discomfort, Wheezing
Clinical narrative: legs were hurting more; sinus pressure; does not feel the same as he did before; chills; arm sore; wheeze; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm sore), WHEEZING (wheeze), PAIN IN EXTREMITY (legs were hurting more), PARANASAL SINUS DISCOMFORT (sinus pressure) and FEELING ABNORMAL (does not feel the same as he did before) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced WHEEZING (wheeze). On an unknown date, the patient experienced PAIN IN EXTREMITY (arm sore), PAIN IN EXTREMITY (legs were hurting more), PARANASAL SINUS DISCOMFORT (sinus pressure), FEELING ABNORMAL (does not feel the same as he did before) and CHILLS (chills). The patient was treated with ALBUTEROL SULFATE ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm sore), WHEEZING (wheeze), PAIN IN EXTREMITY (legs were hurting more), PARANASAL SINUS DISCOMFORT (sinus pressure), FEELING ABNORMAL (does not feel the same as he did before) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: aches in all my joints; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (aches in all my joints) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 048A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 12-Mar-2021, the patient experienced ARTHRALGIA (aches in all my joints). On 12-Mar-2021, ARTHRALGIA (aches in all my joints) had resolved.            Concomitant medications included 2-3 supplements. No treatment information was provided.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Maternal exposure during pregnancy, Pregnancy test, Ultrasound scan
Clinical narrative: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 28-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (1-2 per month) and Asthma in 2015. Concurrent medical conditions included Seasonal allergy and Fruit allergy (Mangoes). Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) and FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) for Seasonal allergy, ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 04-Sep-2020 and the estimated date of delivery was 09-Jul-2021. On 23-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-eighth week of the pregnancy.  On 23-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Oct-2020, Pregnancy test: positive (Positive) Positive. In February 2021, Blood glucose: normal (normal) normal. On 08-Mar-2021, Ultrasound scan: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Estimated date of conception was 09 SEP 2020.  Previous pregnancy end date was 27 SEP 2018 with outcome of full-term live birth.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Dizziness, Headache, Hyperglycaemia, Nausea
Clinical narrative: Blood glucose has been a little higher than usual; dizziness; bellyache; headache; nausea; This spontaneous case was reported by a consumer and describes the occurrence of HYPERGLYCAEMIA (Blood glucose has been a little higher than usual), DIZZINESS (dizziness), ABDOMINAL PAIN UPPER (bellyache), HEADACHE (headache) and NAUSEA (nausea) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036?21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure and Cholesterol.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced DIZZINESS (dizziness), ABDOMINAL PAIN UPPER (bellyache), HEADACHE (headache) and NAUSEA (nausea). On 20-Mar-2021, the patient experienced HYPERGLYCAEMIA (Blood glucose has been a little higher than usual). On 22-Mar-2021, HYPERGLYCAEMIA (Blood glucose has been a little higher than usual), DIZZINESS (dizziness), ABDOMINAL PAIN UPPER (bellyache), HEADACHE (headache) and NAUSEA (nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included blood pressure medication and cholesterol medication. No treatment information was provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: arm pain; very fatigued; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain) and FATIGUE (very fatigued) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B212A) for COVID-19 vaccination.     Concurrent medical conditions included Generalized anxiety disorder and Depression.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm pain) and FATIGUE (very fatigued). The patient was treated with PARACETAMOL (TYLENOL) for Prophylaxis, at an unspecified dose and frequency. On 21-Mar-2021, PAIN IN EXTREMITY (arm pain) had resolved. At the time of the report, FATIGUE (very fatigued) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment information included Tylenol.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Blood glucose, Blood pressure decreased, Diarrhoea
Clinical narrative: dizziness; blurred vision; sore throat; Drop in blood pressure; tiredness; could not lift her arms; lymph nodes swollen; right shoulder hurt; arms, neck hurt/painful; arms, neck hurt/painful; diarrhea; Weakness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), VISION BLURRED (blurred vision), OROPHARYNGEAL PAIN (sore throat), BLOOD PRESSURE DECREASED (Drop in blood pressure) and ASTHENIA (Weakness) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Lumpectomy. Concurrent medical conditions included Drug allergy (phenylephrine.).    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced ASTHENIA (Weakness). On 23-Mar-2021, the patient experienced DIARRHOEA (diarrhea). On 25-Mar-2021, the patient experienced NECK PAIN (arms, neck hurt/painful), MYALGIA (arms, neck hurt/painful) and ARTHRALGIA (right shoulder hurt). On 27-Mar-2021, the patient experienced MOBILITY DECREASED (could not lift her arms) and LYMPHADENOPATHY (lymph nodes swollen). On an unknown date, the patient experienced DIZZINESS (dizziness), VISION BLURRED (blurred vision), OROPHARYNGEAL PAIN (sore throat), BLOOD PRESSURE DECREASED (Drop in blood pressure) and FATIGUE (tiredness). At the time of the report, DIZZINESS (dizziness), VISION BLURRED (blurred vision), OROPHARYNGEAL PAIN (sore throat), BLOOD PRESSURE DECREASED (Drop in blood pressure), ASTHENIA (Weakness), FATIGUE (tiredness), DIARRHOEA (diarrhea), NECK PAIN (arms, neck hurt/painful), MYALGIA (arms, neck hurt/painful), MOBILITY DECREASED (could not lift her arms), LYMPHADENOPATHY (lymph nodes swollen) and ARTHRALGIA (right shoulder hurt) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose: normal (normal) Normal. On an unknown date, Electrocardiogram: normal (normal) Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. Treatment medication included as water.   Most recent FOLLOW-UP information incorporated above includes: On 30-Mar-2021: Significant follow up appended
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Electrocardiogram, Fatigue, Lymphadenopathy, Mobility decreased
Clinical narrative: dizziness; blurred vision; sore throat; Drop in blood pressure; tiredness; could not lift her arms; lymph nodes swollen; right shoulder hurt; arms, neck hurt/painful; arms, neck hurt/painful; diarrhea; Weakness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), VISION BLURRED (blurred vision), OROPHARYNGEAL PAIN (sore throat), BLOOD PRESSURE DECREASED (Drop in blood pressure) and ASTHENIA (Weakness) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Lumpectomy. Concurrent medical conditions included Drug allergy (phenylephrine.).    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced ASTHENIA (Weakness). On 23-Mar-2021, the patient experienced DIARRHOEA (diarrhea). On 25-Mar-2021, the patient experienced NECK PAIN (arms, neck hurt/painful), MYALGIA (arms, neck hurt/painful) and ARTHRALGIA (right shoulder hurt). On 27-Mar-2021, the patient experienced MOBILITY DECREASED (could not lift her arms) and LYMPHADENOPATHY (lymph nodes swollen). On an unknown date, the patient experienced DIZZINESS (dizziness), VISION BLURRED (blurred vision), OROPHARYNGEAL PAIN (sore throat), BLOOD PRESSURE DECREASED (Drop in blood pressure) and FATIGUE (tiredness). At the time of the report, DIZZINESS (dizziness), VISION BLURRED (blurred vision), OROPHARYNGEAL PAIN (sore throat), BLOOD PRESSURE DECREASED (Drop in blood pressure), ASTHENIA (Weakness), FATIGUE (tiredness), DIARRHOEA (diarrhea), NECK PAIN (arms, neck hurt/painful), MYALGIA (arms, neck hurt/painful), MOBILITY DECREASED (could not lift her arms), LYMPHADENOPATHY (lymph nodes swollen) and ARTHRALGIA (right shoulder hurt) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose: normal (normal) Normal. On an unknown date, Electrocardiogram: normal (normal) Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. Treatment medication included as water.   Most recent FOLLOW-UP information incorporated above includes: On 30-Mar-2021: Significant follow up appended
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Neck pain, Oropharyngeal pain, Vision blurred
Clinical narrative: dizziness; blurred vision; sore throat; Drop in blood pressure; tiredness; could not lift her arms; lymph nodes swollen; right shoulder hurt; arms, neck hurt/painful; arms, neck hurt/painful; diarrhea; Weakness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), VISION BLURRED (blurred vision), OROPHARYNGEAL PAIN (sore throat), BLOOD PRESSURE DECREASED (Drop in blood pressure) and ASTHENIA (Weakness) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Lumpectomy. Concurrent medical conditions included Drug allergy (phenylephrine.).    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced ASTHENIA (Weakness). On 23-Mar-2021, the patient experienced DIARRHOEA (diarrhea). On 25-Mar-2021, the patient experienced NECK PAIN (arms, neck hurt/painful), MYALGIA (arms, neck hurt/painful) and ARTHRALGIA (right shoulder hurt). On 27-Mar-2021, the patient experienced MOBILITY DECREASED (could not lift her arms) and LYMPHADENOPATHY (lymph nodes swollen). On an unknown date, the patient experienced DIZZINESS (dizziness), VISION BLURRED (blurred vision), OROPHARYNGEAL PAIN (sore throat), BLOOD PRESSURE DECREASED (Drop in blood pressure) and FATIGUE (tiredness). At the time of the report, DIZZINESS (dizziness), VISION BLURRED (blurred vision), OROPHARYNGEAL PAIN (sore throat), BLOOD PRESSURE DECREASED (Drop in blood pressure), ASTHENIA (Weakness), FATIGUE (tiredness), DIARRHOEA (diarrhea), NECK PAIN (arms, neck hurt/painful), MYALGIA (arms, neck hurt/painful), MOBILITY DECREASED (could not lift her arms), LYMPHADENOPATHY (lymph nodes swollen) and ARTHRALGIA (right shoulder hurt) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose: normal (normal) Normal. On an unknown date, Electrocardiogram: normal (normal) Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. Treatment medication included as water.   Most recent FOLLOW-UP information incorporated above includes: On 30-Mar-2021: Significant follow up appended
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore left arm) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A 028L20A and 038A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included GABAPENTIN, SPIRONOLACTONE, FUROSEMIDE, OMEPRAZOLE, FOLIC ACID, VITAMIN B12 NOS (VITAMIN B 12 [VITAMIN B12 NOS]), POTASSIUM, ELDERBERRY [SAMBUCUS NIGRA], GARLIC [ALLIUM SATIVUM], TURMERIC [CURCUMA LONGA RHIZOME], CALCIUM, MAGNESIUM, LACTULOSE and UBIDECARENONE (COQ 10) for an unknown indication.   On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore left arm). The patient was treated with PARACETAMOL (TYLENOL) for Prophylaxis, at an unspecified dose and frequency and TRAMADOL for Prophylaxis, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore left arm) outcome was unknown.            Treatment information includes Tylenol and Tramadol.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-054284:patient link, 1st dose case
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Rash
Clinical narrative: RASH; RASH WITH A LOT OF BUMPS ON THE NECK; A LOT OF BUMPS ON LOWER LYMPH NODES; This spontaneous case was reported by a consumer and describes the occurrence of RASH (RASH), RASH (RASH WITH A LOT OF BUMPS ON THE NECK) and LYMPHADENOPATHY (A LOT OF BUMPS ON LOWER LYMPH NODES) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (RASH), RASH (RASH WITH A LOT OF BUMPS ON THE NECK) and LYMPHADENOPATHY (A LOT OF BUMPS ON LOWER LYMPH NODES). At the time of the report, RASH (RASH), RASH (RASH WITH A LOT OF BUMPS ON THE NECK) and LYMPHADENOPATHY (A LOT OF BUMPS ON LOWER LYMPH NODES) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Lymphadenopathy, Ultrasound scan
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of LYMPHADENOPATHY (Lymph node in upper clavicle) and FATIGUE (Fatigue) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037K20A and 037L20A) for COVID-19 vaccination.  The patient's past medical history included No adverse event. On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Jan-2021, the patient experienced LYMPHADENOPATHY (Lymph node in upper clavicle). On 03-Feb-2021, the patient experienced FATIGUE (Fatigue). The patient was treated with CEFALEXIN (KEFLEX [CEFALEXIN]) for Prophylaxis, at a dose of 500 mg. On 06-Feb-2021, FATIGUE (Fatigue) had resolved. At the time of the report, LYMPHADENOPATHY (Lymph node in upper clavicle) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Ultrasound scan: 1.7 centimetre (abnormal) 1.7cm in size and there is blood going through it. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. Treatment information included keflex 500 mg.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: drowsiness; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (drowsiness) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced SOMNOLENCE (drowsiness). At the time of the report, SOMNOLENCE (drowsiness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Sex: F
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: experienced chills for the day; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (experienced chills for the day) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     The patient's past medical history included No adverse event.   On 13-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced CHILLS (experienced chills for the day). At the time of the report, CHILLS (experienced chills for the day) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA and HEADACHE in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NAUSEA and HEADACHE. At the time of the report, NAUSEA and HEADACHE outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: Shortness of breath; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath ) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Shortness of breath ). At the time of the report, DYSPNOEA (Shortness of breath ) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication were provided. No concomitant medication were provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Inappropriate schedule of product administration; A spontaneous report was received from a HCP concerning a 31-year-old female patient , who received Moderna's COVID-19 vaccine (mRNA-1273) and administered second dose of Moderna vaccine to a patient 22 days after first dose.  The patient's medical history was not provided. Concomitant medication as provided by the reporter was unknown.  On 23 Mar 2021, prior to the onset of the event, the patient received their second of two planned doses of mRNA-1273 (Lot number: 045A21A) through intramuscular route in left arm for prophylaxis of COVID-19 infection and administered second dose 22 days after first dose  No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not applicable.  The outcome of the event inappropriate schedule of vaccine administration was considered resolved.; Sender's Comments: This report refers to a case of inappropriate schedule of vaccine administered for mRNA-1273, lot # 045A21A  with no associated AEs.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Pain in extremity, Rash, Rash erythematous
Clinical narrative: circular rash; red rash; bruised arm; arm pain; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 23-Mar-2021 and was forwarded to Moderna on 23-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of RASH (circular rash), PAIN IN EXTREMITY (arm pain), CONTUSION (bruised arm) and RASH ERYTHEMATOUS (red rash) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Diabetes (has discontinued diabetes medication within the past month.). Concurrent medical conditions included Breast cancer and Weight loss.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm pain). On 16-Mar-2021, the patient experienced CONTUSION (bruised arm). On 23-Mar-2021, the patient experienced RASH (circular rash) and RASH ERYTHEMATOUS (red rash). At the time of the report, RASH (circular rash), PAIN IN EXTREMITY (arm pain), CONTUSION (bruised arm) and RASH ERYTHEMATOUS (red rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included Chemo pill. No treatment information was provided.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever; fever chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) and PYREXIA (fever chills) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A71H) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (back in Dec-2020.).    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced PYREXIA (fever) and PYREXIA (fever chills). At the time of the report, PYREXIA (fever) and PYREXIA (fever chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Feeling hot, Headache, Myalgia
Clinical narrative: headache, body aches, chills, sniffing, cough and she felt her body was warm; headache, body aches, chills, sniffing, cough and she felt her body was warm; headache, body aches, chills, sniffing, cough and she felt her body was warm; headache, body aches, chills, sniffing, cough and she felt her body was warm; headache, body aches, chills, sniffing, cough and she felt her body was warm; headache, body aches, chills, sniffing, cough and she felt her body was warm; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (headache, body aches, chills, sniffing, cough and she felt her body was warm), FEELING HOT (headache, body aches, chills, sniffing, cough and she felt her body was warm), RHINORRHOEA (headache, body aches, chills, sniffing, cough and she felt her body was warm), MYALGIA (headache, body aches, chills, sniffing, cough and she felt her body was warm) and HEADACHE (headache, body aches, chills, sniffing, cough and she felt her body was warm) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetic. Concomitant products included INSULIN for an unknown indication.   On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced COUGH (headache, body aches, chills, sniffing, cough and she felt her body was warm), FEELING HOT (headache, body aches, chills, sniffing, cough and she felt her body was warm), RHINORRHOEA (headache, body aches, chills, sniffing, cough and she felt her body was warm), MYALGIA (headache, body aches, chills, sniffing, cough and she felt her body was warm), HEADACHE (headache, body aches, chills, sniffing, cough and she felt her body was warm) and CHILLS (headache, body aches, chills, sniffing, cough and she felt her body was warm). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, COUGH (headache, body aches, chills, sniffing, cough and she felt her body was warm), FEELING HOT (headache, body aches, chills, sniffing, cough and she felt her body was warm), RHINORRHOEA (headache, body aches, chills, sniffing, cough and she felt her body was warm), MYALGIA (headache, body aches, chills, sniffing, cough and she felt her body was warm), HEADACHE (headache, body aches, chills, sniffing, cough and she felt her body was warm) and CHILLS (headache, body aches, chills, sniffing, cough and she felt her body was warm) had not resolved.            Concomitant medications included diabetic medication.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: headache, body aches, chills, sniffing, cough and she felt her body was warm; headache, body aches, chills, sniffing, cough and she felt her body was warm; headache, body aches, chills, sniffing, cough and she felt her body was warm; headache, body aches, chills, sniffing, cough and she felt her body was warm; headache, body aches, chills, sniffing, cough and she felt her body was warm; headache, body aches, chills, sniffing, cough and she felt her body was warm; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (headache, body aches, chills, sniffing, cough and she felt her body was warm), FEELING HOT (headache, body aches, chills, sniffing, cough and she felt her body was warm), RHINORRHOEA (headache, body aches, chills, sniffing, cough and she felt her body was warm), MYALGIA (headache, body aches, chills, sniffing, cough and she felt her body was warm) and HEADACHE (headache, body aches, chills, sniffing, cough and she felt her body was warm) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetic. Concomitant products included INSULIN for an unknown indication.   On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced COUGH (headache, body aches, chills, sniffing, cough and she felt her body was warm), FEELING HOT (headache, body aches, chills, sniffing, cough and she felt her body was warm), RHINORRHOEA (headache, body aches, chills, sniffing, cough and she felt her body was warm), MYALGIA (headache, body aches, chills, sniffing, cough and she felt her body was warm), HEADACHE (headache, body aches, chills, sniffing, cough and she felt her body was warm) and CHILLS (headache, body aches, chills, sniffing, cough and she felt her body was warm). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, COUGH (headache, body aches, chills, sniffing, cough and she felt her body was warm), FEELING HOT (headache, body aches, chills, sniffing, cough and she felt her body was warm), RHINORRHOEA (headache, body aches, chills, sniffing, cough and she felt her body was warm), MYALGIA (headache, body aches, chills, sniffing, cough and she felt her body was warm), HEADACHE (headache, body aches, chills, sniffing, cough and she felt her body was warm) and CHILLS (headache, body aches, chills, sniffing, cough and she felt her body was warm) had not resolved.            Concomitant medications included diabetic medication.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: Difficulty breathing; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty breathing) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     Concurrent medical conditions included COPD and Allergy. Concomitant products included GUAIFENESIN (MUCINEX), IPRATROPIUM BROMIDE, SALBUTAMOL SULFATE (DUONEB), FLUTICASONE PROPIONATE (FLOVENT) and SALBUTAMOL SULFATE (ALBUTEROL [SALBUTAMOL SULFATE]) for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced DYSPNOEA (Difficulty breathing). At the time of the report, DYSPNOEA (Difficulty breathing) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Outcome of the event Dyspnoea updated to recovered.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Oral discomfort, Oral herpes, Oropharyngeal pain
Clinical narrative: lips were swollen, especially the bottom lip, lip swelling decreases during the day but increases at night; feels strange sensations in her lips; fever blister on lip; sore throat; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), ORAL HERPES (fever blister on lip), LIP SWELLING (lips were swollen, especially the bottom lip, lip swelling decreases during the day but increases at night) and ORAL DISCOMFORT (feels strange sensations in her lips) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat). On 15-Mar-2021, the patient experienced ORAL HERPES (fever blister on lip). On 20-Mar-2021, the patient experienced LIP SWELLING (lips were swollen, especially the bottom lip, lip swelling decreases during the day but increases at night) and ORAL DISCOMFORT (feels strange sensations in her lips). The patient was treated with CAMPHOR, PHENOL (CAMPHO PHENIQUE PAIN RELIEVING ANTISEPTIC GEL) ongoing since an unknown date at an unspecified dose and frequency. On 18-Mar-2021, ORAL HERPES (fever blister on lip) had resolved. At the time of the report, OROPHARYNGEAL PAIN (sore throat), LIP SWELLING (lips were swollen, especially the bottom lip, lip swelling decreases during the day but increases at night) and ORAL DISCOMFORT (feels strange sensations in her lips) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Rash, Sinus disorder
Clinical narrative: joint pain all over body; rash; sinus problems; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (joint pain all over body), RASH (rash) and SINUS DISORDER (sinus problems) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced ARTHRALGIA (joint pain all over body), RASH (rash) and SINUS DISORDER (sinus problems). At the time of the report, ARTHRALGIA (joint pain all over body), RASH (rash) and SINUS DISORDER (sinus problems) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided.